Tomimoto Hidekazu

トミモトヒデカズ | Tomimoto Hidekazu

Affiliation and department：

Research field (2)： Neuroanatomy and physiology , Neurology

Research keywords (4)： Neuroimaging , Neuropathology , Cerebrovascular disease , Dementia

Research theme for competitive and other funds (19)：

2023 - 2027 若年性アルツハイマー病の原因解明と早期血液バイオマーカーの探索
2019 - 2023 認知症における血中エクソソーム内包酸化損傷タンパク質の変動解析とリスク診断
2019 - 2022 A strategic research to establish blood biomarker for cerebral amyloid angiopathy and disease modifying therapy in dementia.
2016 - 2019 ex vivo imaging of cerebral amyloid angiopathy and its associated lesions using micro-MRI
2015 - 2019 Development of a PET imaging agent and disease biomarker for Alzheimer's disease.

Show all

Papers (535)：

Yukito Ueda, Ko Matsuo, Kana Matsuda, Ryo Momosaki, Akihiro Shindo, Hidekazu Tomimoto. [Behavioral variant of frontotemporal dementia with stereotypic speech: a case report]. Rinsho shinkeigaku = Clinical neurology. 2024
Yuichiro Ii, Hidehiro Ishikawa, Akisato Nishigaki, Takaya Utsunomiya, Naoko Nakamura, Yoshinori Hirata, Hirofumi Matsuyama, Hiroyuki Kajikawa, Keita Matsuura, Kana Matsuda, et al. Superficial small cerebellar infarcts in cerebral amyloid angiopathy on 3 T MRI: A preliminary study. Journal of the neurological sciences. 2024. 459. 122975-122975
Kazuo Washida, Satoshi Saito, Tomotaka Tanaka, Yuriko Nakaoku, Hiroyuki Ishiyama, Soichiro Abe, Takehito Kuroda, Shinsaku Nakazawa, Chikage Kakuta, Katsuhiro Omae, et al. A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cerebral Circulation - Cognition and Behavior. 2024. 6. 100211-100211
Koichi Miyashita, Yuichiro Ii, Hirofumi Matsuyama, Atsushi Niwa, Yosuke Kawana, Soshi Shibata, Narihiro Minami, Ichizo Nishino, Hidekazu Tomimoto. Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient. Internal medicine (Tokyo, Japan). 2023. 62. 20. 3027-3031
Keita Matsuura, Yuichiro Ii, Masayuki Maeda, Ken-Ichi Tabei, Masayuki Satoh, Maki Umino, Hiroyuki Kajikawa, Tommohiro Araki, Naoko Nakamura, Hirofumi Matsuyama, et al. Pulvinar quantitative susceptibility mapping predicts visual hallucinations post-deep brain stimulation in Parkinson's disease. Brain and behavior. 2023. e3263

ｍore...

MISC (144)：

宇都宮貴哉, 田村麻子, 西口大和, 松山裕文, 原田純直, 新堂晃大, 冨本秀和. COVID-19ワクチン接種後に視神経炎を発症し,経過中に細菌性髄膜炎様の画像所見を呈した抗MOG抗体関連疾患の1例. 臨床神経学(Web). 2023. 63. 3
松山裕文, 平田佳寛, 新堂晃大, 冨本秀和, 冨本秀和. A case of metachromatic leukodystrophy with characteristic white matter lesions. 神経治療学(Web). 2023. 40. 2
宮下紘一, 伊井裕一郎, 松山裕文, 冨本秀和, 丹羽篤, 川名陽介, 柴田創司, 西野一三. 遺伝歴がなく筋病理所見が診断に有用であった筋強直性ジストロフィー2型(DM2)の1例. 臨床神経学(Web). 2022. 62. 3
水谷あかね, 新堂晃大, 加藤奈津子, 伊井裕一郎, 松山裕文, 谷口彰, 冨本秀和. 免疫療法が奏効した慢性進行性小脳失調症の1例. 神経治療学(Web). 2022. 39. 6
松浦慶太, 松浦慶太, 宇都宮貴哉, 松山裕文, 梶川博之, 荒木朋浩, 冨本秀和. Relationship between drug use and motor function after subthalamic deep brain stimulation. 神経治療学(Web). 2022. 39. 5

ｍore...

Patents (7)：

ｍore...

Education (2)：

1984 - 1988 Kyoto University
1975 - 1981 Kyoto University Faculty of Medicine

Professional career (1)：

医学博士 (京都大学)

Committee career (14)：

2017 - 現在日本脳ドック学会理事
2016 - 現在日本神経学会理事
2013 - 現在日本神経治療学会理事
2013 - 現在日本認知症学会理事
2013 - 現在日本脳卒中学会理事

Show all

Association Membership(s) (11)：

American Heart Association , American Academy of Neurology , The Japanese Society of Neurpathology , The Japan Geriatrics Society , The Japanese Society of Internal Medicine , The Japan Brain Dock Society , The Japanese Society of Cerebral Blood Flow and Metabolism , Japanese Society of Neurological Therapeutics , Japan Society for Dementia Research , The Japan Stroke Society , Japanese Society of Neurology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page